Decreased insulin secretion and dyslipidemia coexist in subjects with impaired fasting glucose (Q43857802)

27 November 2017

Decreased insulin secretion and dyslipidemia coexist in subjects with impaired fasting glucose (English)

1 reference

27 November 2017

1 reference

Kayo Ozaki

1

1 reference

27 November 2017

Masamichi Okubo

2

1 reference

27 November 2017

Hiroshi Mori

3

1 reference

27 November 2017

Kazuyo Mito

4

1 reference

27 November 2017

Hitoshi Hara

5

1 reference

27 November 2017

Nobuoki Kohno

6

1 reference

27 November 2017

1 February 2002

1 reference

Diabetes Research and Clinical Practice

27 November 2017

1 reference

27 November 2017

55

1 reference

27 November 2017

2

1 reference

27 November 2017

159-164

1 reference

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Increased risk factors for coronary artery disease in Japanese subjects with hyperinsulinemia or glucose intolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Reduced prevalence of diabetes according to 1997 American Diabetes Association criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmö Preventive Trial with diet and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2801%2900315-1

7 January 2021

10.1016/S0168-8227(01)00315-1

Identifiers

DOI

1 reference

27 November 2017

1 reference